By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Sunovion Pharmaceuticals Inc. 

84 Waterford Drive

Marlborough  Massachusetts  01752  U.S.A.
Phone: 508-481-6700 Fax:


SEARCH JOBS




Collaborations

Acadia  ACADIA has formed a broad CNS collaboration with Sepracor for the discovery and development of new drug candidates against muscarinic receptors.

Cubist 





Company News
Sunovion Pharmaceuticals Inc. Announces Results Of Phase III Long-Term Safety Study Showing SUN-101/Eflow® (Glycopyrrolate) Was Well-Tolerated In People With Moderate-To-Very Severe Chronic Obstructive Pulmonary Disease (COPD) 7/22/2016 8:13:12 AM
PARI Pharma's Investigational Closed eFlow Nebulizer System Used In Two Successful Phase 3 Clinical Studies Evaluating Sunovion Pharmaceuticals Inc.'s SUN-101 (Glycopyrrolate) In People With Moderate-To-Very Severe Chronic Obstructive Pulmonary Disease (COPD) 6/7/2016 8:28:06 AM
Sunovion Pharmaceuticals Inc.Announces Publication Of Data Evaluating The Long-Term Safety And Tolerability Of Latuda (Lurasidone Hcl) In The Treatment Of Bipolar Depression 5/23/2016 10:42:15 AM
American Thoracic Society And Sunovion Pharmaceuticals Inc. Release Landmark Survey Of Pulmonologists’ Attitudes And Practices With Inhalation Devices For COPD At The ATS 2016 International Conference 5/16/2016 11:29:36 AM
Sunovion Pharmaceuticals Inc. Announces Health Outcomes Data On Exacerbation-Related Hospitalizations That Support The Use Of Brovana (Arformoterol Tartrate) Inhalation Solution In People With Moderate-To-Severe COPD At The 2016 American Thoracic Society Conference 5/16/2016 10:48:36 AM
Sunovion Pharmaceuticals Inc. To Present Data On Latuda (Lurasidone Hcl) At The 169th Annual Meeting Of The American Psychiatric Association 5/12/2016 11:07:40 AM
Sunovion Pharmaceuticals Inc. Presents New Health Outcomes Data Supporting Brovana (Arformoterol Tartrate) Inhalation Solution In People With Moderate-To-Severe COPD At The 2016 American Thoracic Society International Conference 5/4/2016 10:56:57 AM
Sunovion Pharmaceuticals Inc. Announces Positive Results From Two Phase III Clinical Studies Evaluating SUN-101/Eflow (Glycopyrrolate) In People With Moderate-To-Very Severe Chronic Obstructive Pulmonary Disease (COPD) 4/27/2016 10:28:06 AM
Sunovion Pharmaceuticals Inc. Announces Results Of Health Outcomes Analyses Supporting The Use Of Aptiom (Eslicarbazepine Acetate) In People With Partial-Onset Seizures At The 68th American Academy of Neurology Annual Meeting 4/15/2016 9:15:24 AM
Sunovion Pharmaceuticals Inc. To Present Data Analyses Supporting Use Of Aptiom (eslicarbazepine acetate) At The 68th American American Academy of Neurology Annual Meeting 4/6/2016 9:42:29 AM
12345678910...
//-->